CN Patent

CN119462607B — 一类喹啉酮衍生物及其用途

Assigned to Nanjing Ningdan New Drug Technology Co ltd · Expires 2025-11-28 · 0y expired

What this patent protects

本发明公开了一类喹啉酮衍生化合物及其药物组合物和用途。本发明中的喹啉酮衍生物能够拮抗CGRP所诱导的腹泻，该类化合物在制备治疗肠易激综合征药物中有良好的应用前景。

USPTO Abstract

本发明公开了一类喹啉酮衍生化合物及其药物组合物和用途。本发明中的喹啉酮衍生物能够拮抗CGRP所诱导的腹泻，该类化合物在制备治疗肠易激综合征药物中有良好的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN119462607B
Jurisdiction
CN
Classification
—
Expires
2025-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Ningdan New Drug Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.